Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
BioZorb Marker Lawsuits Involving 100 Different Plaintiffs Pending in District of Massachusetts Lawsuits allege recalled BioZorb Markers failed to absorb after breast cancer treatments, resulting in painful complications and need for additional surgery. December 12, 2024 Irvin Jackson Add Your Comments According to recently released court documents, the number of plaintiffs who are pursuing BioZorb lawsuits has now reached the triple digits, and the number of claims is likely to continue growing as more women learn that the recalled breast tissue marker failed to absorb as intended after cancer treatments. The BioZorb Marker is a small implant commonly used among breast cancer survivors and others who require targeted radiation therapy. It is designed to gradually break down and dissolve into a patient’s body, but users have reported experiencing painful BioZorb complications when the tissue marker failed to absorb into the body, often resulting in the need for surgical removal. As a result of the problems, the manufacturer recently issued a BioZorb Marker recall on October 25, 2024, urging doctors to return any devices that have not been implanted and closely monitor patients for signs of problems, including pain, infection, rash, fluid buildup or migration of the device. As of December 4, lawyers report that BioZorb Marker lawsuits have been filed on behalf of 100 different plaintiffs. Each of the claims have been brought in the U.S. District Court for the District of Massachusetts, where the manufacturer’s U.S. headquarters are located. However, as more women learn that complications they experienced in recent years may be the result of a defective design, the size and scope of the litigation is expected to continue to increase. BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions raised in the litigation, all of the lawsuits are currently centralized before U.S. District Judge Allison D. Burroughs, who is guiding the parties through coordinated discovery into common issues impacting all claims. To help promote potential BioZorb recall settlement negotiations, Judge Burroughs previously established a bellwether process, where a small group of representative claims are being prepared for early trial dates to help gauge how juries may respond to evidence and expert testimony that is likely to be repeated throughout the litigation. Each side chose five potential BioZorb bellwether trial candidates in August 2024, as part of an initial discovery pool. As part of a regular series of status conferences being held throughout the litigation, plaintiffs and defendants submitted a joint report (PDF) on December 3, before a status conference held the next day. According to the report, there are a total of 22 complaints currently pending before Judge Burroughs, but most of them involve multiple plaintiffs. At least 100 different individuals are now pursuing BioZorb claims. December 2024 BioZorb Lawsuit Update The parties updated Judge Burroughs on the status of discovery in the 10 bellwether selections, indicating that the cases are proceeding on schedule. Core depositions are expected to be complete by December 16, and each side will then strike three lawsuits from the discovery pool, resulting in four claims that will be eligible for the first trial dates. Judge Burroughs had ordered the parties to file a case management order by December 19, identifying the four remaining bellwether trial cases and proposing a method for selecting the order in which the cases will go before juries. However, the parties are in disagreement on how to handle the multi-plaintiff complaints, indicating they will file competing proposed case management orders. “The Parties have met and conferred but were unable to reach agreement on bellwether trial selection and structure. Specifically, Plaintiffs intend to ask the Court for a multi-plaintiff trial comprised of multiple Trial Pool Plaintiffs,” the status report states. “Hologic objects to a multi-plaintiff trial and intends to propose a single-plaintiff trial structure.” While the outcome of these first trials will not have any binding impact on other lawsuits, they will be closely watched to gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation, and the average lawsuit payout may have a substantial impact on the amounts of BioZorb recall settlements the manufacturer may be forced to pay in the future. Tags: BioZorb, BioZorb Recall, Breast Cancer, Cancer, Radiation Therapy Find Out If You Qualify for BioZorb Failure Compensation More BioZorb Lawsuit Stories Court Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker March 26, 2025 Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025 Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker March 12, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)